Traci L. Bricker

The paper develops and tests new inhibitors of TMPRSS2 to block replication of SARS-CoV-2 and H1N1 influenza virus.

This study shows molnupiravir reduces BRBV infection and disease in mice by lowering virus burden and improving immune and clinical outcomes.

This paper demonstrates that MM3122, a host cell serine protease inhibitor, effectively inhibits SARS-CoV-2 replication and reduces disease severity in mice, both prophylactically and therapeutically.

This study evaluates the efficacy of NVX-CoV2373 and NVX-CoV2540 nanoparticle vaccines against the Omicron BA.5 variant in Syrian hamsters, showing reduced viral infection and better protection compared to mRNA vaccines.